Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHITT Japan pediatric hepatic tumor trial
jRCTs061180004Active, not recruiting
- Start
- Nov 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Randomised, open-label trial of cisplatin, doxorubicin, fluorouracil, vincristine, carboplatin and 5 more in hepatoblastoma and hepatocellular carcinoma (HCC) (14 arms). Primary endpoints: Treatment reduction feasibility in low-risk hepatoblastoma, Comparison of regimens in intermediate-risk hepatoblastoma and 3 more. Started Nov 2018; status: active, not recruiting.
02
Drugs
cisplatindoxorubicinfluorouracilvincristinecarboplatin
03
Conditions
hepatoblastomahepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCTs061180004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180004.